Capricor Therapeutics, Inc. SEC filings CAPR
Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 23, 2025 | — |
| CORRESP | Letter to the SEC | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2024 | — |
| EFFECT | Filing | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| CORRESP | Letter to the SEC | Oct 15, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| EFFECT | Filing | Jun 16, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| CORRESP | Letter to the SEC | Jun 14, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2021 | — |
| EFFECT | Filing | May 19, 2020 | — |
| CORRESP | Letter to the SEC | May 15, 2020 | — |
| UPLOAD | Letter from the SEC | May 14, 2020 | — |
| EFFECT | Filing | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 13, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2019 | — |
| EFFECT | Filing | Jul 18, 2019 | — |
| CORRESP | Letter to the SEC | Jul 15, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2018 | — |
| CT ORDER | Filing | Aug 29, 2018 | — |
| CT ORDER | Filing | Apr 19, 2018 | — |
| EFFECT | Filing | Jul 17, 2017 | — |
| CORRESP | Letter to the SEC | Jul 13, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| D | Filing | May 19, 2017 | — |
| CT ORDER | Filing | Dec 27, 2016 | — |
| CT ORDER | Filing | Oct 20, 2016 | — |
| CT ORDER | Filing | Jul 27, 2016 | — |
| EFFECT | Filing | Jun 30, 2016 | — |
| CORRESP | Letter to the SEC | Jun 28, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2016 | — |
| D | Filing | Mar 29, 2016 | — |
| EFFECT | Filing | Oct 26, 2015 | — |
| CORRESP | Letter to the SEC | Oct 22, 2015 | — |
| CT ORDER | Filing | Oct 20, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2015 | — |
| EFFECT | Filing | Aug 7, 2015 | — |
| EFFECT | Filing | Jun 11, 2015 | — |
| 15-12B | Deregistration | Apr 21, 2015 | — |
| CT ORDER | Filing | Apr 2, 2015 | — |
| EFFECT | Filing | Mar 30, 2015 | — |
| 8-A12B | Filing | Mar 5, 2015 | — |
| D | Filing | Feb 19, 2015 | — |
| D | Filing | Feb 3, 2015 | — |
| EFFECT | Filing | Jun 6, 2014 | — |
| CORRESP | Letter to the SEC | Jun 4, 2014 | — |
| CT ORDER | Filing | Jun 4, 2014 | — |
| CT ORDER | Filing | May 13, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2014 | — |
| D | Filing | Feb 24, 2014 | — |
| D | Filing | Dec 5, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2013 | — |
| CORRESP | Letter to the SEC | Oct 4, 2013 | — |
| EFFECT | Filing | May 7, 2012 | — |
| NT 10-K | Form nt 10-k | Apr 2, 2012 | Dec 31, 2011 |
| EFFECT | Filing | Aug 8, 2011 | — |
| CORRESP | Letter to the SEC | Aug 4, 2011 | — |
| CT ORDER | Filing | Aug 3, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2011 | — |
| 25-NSE | Delisting notice | Jul 13, 2011 | — |
| D | Filing | Jun 27, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2011 | — |
| CORRESP | Letter to the SEC | Mar 23, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2011 | — |
| CORRESP | Letter to the SEC | Mar 15, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2010 | — |
| CORRESP | Letter to the SEC | Aug 9, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2010 | — |
| CERTNAS | Auto-generated paper document | Apr 22, 2010 | — |
| 8-A12B | Filing | Apr 22, 2010 | — |
| EFFECT | Filing | Mar 12, 2010 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2009 | — |
| CORRESP | Letter to the SEC | Oct 1, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2009 | — |
| EFFECT | Filing | Aug 25, 2009 | — |
| D | Filing | Jul 15, 2009 | — |
| CT ORDER | Filing | Sep 19, 2008 | — |
| CERTNAS | Auto-generated paper document | May 12, 2008 | — |
| 8-A12B | Form 8-a12b | May 9, 2008 | — |
| 10KSB | Form 10-ksb | Mar 27, 2008 | Dec 31, 2007 |
| 10QSB | Form 10-qsb | Nov 14, 2007 | Sep 30, 2007 |
| EFFECT | Filing | Nov 6, 2007 | — |
| CORRESP | Letter to the SEC | Nov 6, 2007 | — |
| SB-2/A | Filing | Nov 2, 2007 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2007 | — |
| SB-2 | Filing | Oct 22, 2007 | — |
| REGDEX | Auto-generated paper document | Sep 26, 2007 | — |
| SC 14F1 | Filing | Aug 22, 2007 | — |
| 10QSB | Filing | Jul 20, 2007 | Jun 30, 2007 |
| 10QSB | Filing | May 14, 2007 | Mar 31, 2007 |
| 10KSB | Filing | Feb 7, 2007 | Dec 31, 2006 |
| CORRESP | Letter to the SEC | Nov 17, 2006 | — |
| 10QSB | Form 10-qsb smi products | Nov 14, 2006 | Sep 30, 2006 |
| UPLOAD | Letter from the SEC | Nov 9, 2006 | — |
| SC 14F1 | Filing | Aug 15, 2006 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2006 | — |
| 10QSB | Form 10-qsb - 06-30-06 | Aug 3, 2006 | Jun 30, 2006 |
| 10KSB/A | Form 10-ksb amendment #2 12-31-05 | May 23, 2006 | Dec 31, 2005 |
| CORRESP | Letter to the SEC | May 23, 2006 | — |
| 10QSB | Form 10-qsb - 03-31-06 | May 15, 2006 | Mar 31, 2006 |
| UPLOAD | Letter from the SEC | Apr 18, 2006 | — |
| 10KSB/A | Form 10-ksb - amendment #1 (12-30-05) | Apr 4, 2006 | Dec 31, 2005 |
| 10KSB | Form 10-ksb | Mar 31, 2006 | Dec 31, 2005 |
| 10QSB | Form 10-qsb 09-30-05 | Nov 21, 2005 | Sep 30, 2005 |
| NT 10-Q | Form nt 10-q extension 09-30-05 | Nov 15, 2005 | Sep 30, 2005 |
| 10QSB | Form 10-qsb - 06/30/05 | Aug 22, 2005 | Jun 30, 2005 |
| NT 10-Q | Form nt 10-q extension | Aug 12, 2005 | Jun 30, 2005 |
| 10QSB | Form 10-qsb 03-31-05 | May 16, 2005 | Mar 31, 2005 |
| 10KSB | Form 10-ksb (12-31-04) | Mar 30, 2005 | Dec 31, 2004 |
| 10QSB | Form 10-qsb dated 09-30-04 | Nov 19, 2004 | Sep 30, 2004 |
| NT 10-Q | Form 10-qsb extension 09-30-04 | Nov 12, 2004 | Sep 30, 2004 |
| 10QSB | Form 10-qsb (06/30/04) | Aug 16, 2004 | Jun 30, 2004 |
| 10QSB | Form 10qsb dated 03-31-04 | May 17, 2004 | Mar 31, 2004 |
| 10KSB | Form 10-ksb 12-31-03 | Mar 30, 2004 | Dec 31, 2003 |
| 10QSB | Form 10-qsb - 09/30/03 | Nov 13, 2003 | Sep 30, 2003 |
| 10QSB | Form 10-qsb dated 06-30-03 | Aug 14, 2003 | Jun 30, 2003 |
| 10QSB | Form 10-qsb dated 03-31-03 | May 22, 2003 | Mar 31, 2003 |
| NT 10-Q | Extension - form 10-qsb - 03/31/03 | May 14, 2003 | Mar 31, 2003 |
| 10KSB | Form 10-ksb - 12/31/02 | Apr 15, 2003 | Dec 31, 2002 |
| NT 10-K | Form 12b-25 extension | Mar 31, 2003 | Dec 31, 2002 |
| 10QSB | Form 10qsb 093002 | Nov 14, 2002 | Sep 30, 2002 |
| 10QSB | Form 10-qsb period 06/30/02 | Aug 14, 2002 | Jun 30, 2002 |
| 10QSB | Form 10-qsb - period 03/31/02 | May 17, 2002 | Mar 31, 2002 |
| NT 10-Q | Form 12b-25 - extension form 10-q | May 14, 2002 | Mar 31, 2002 |
| 10KSB | Form 10-ksb dated december 31, 2001 | Apr 15, 2002 | Dec 31, 2001 |
| NT 10-K | Notification of late filing | Mar 28, 2002 | Dec 31, 2001 |
| SB-2/A | Form sb-2 amendment #3 | Jul 31, 2001 | — |
| SB-2/A | Form sb2/a no. 2 dated june 2001 | Jun 7, 2001 | — |
| SB-2/A | Form sb-2 amendment no. 1 | Apr 30, 2001 | — |
| SB-2 | Form sb-2 | Feb 7, 2001 | — |
Showing 135 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133869
- Former names
- Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.